References
- Damber JE, Aus G. Prostate cancer. Lancet 2008;371: 1710–21.
- Whitmore WF, Jr. Hormone therapy in prostatic cancer. Am J Med 1956;21:697–713.
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225–49.
- Bratt O, Berglund A, Adolfsson J, Johansson JE, Tornblom M, Stattin P. Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: A population-based study from the National Prostate Cancer Register of Sweden. Scand J Urol Nephrol 2010. [Epub 2010-07-14].
- Albertsen PC. When is active surveillance the appropriate treatment for prostate cancer? Acta Oncol 2010 (this issue).
- Conti SL, Dall'era M, Fradet V, Cowan JE, Simko J, Carroll PR. Pathological outcomes of candidates for active surveillance of prostate cancer. J Urol 2009;181:1628–33; Discussion 33–4.
- Ploussard G, Salomon L, Xylinas E, Allory Y, Vordos D, Hoznek A, . Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance—does the risk of misclassification vary according to biopsy criteria? J Urol 2010;183:539–44.
- Duffield AS, Lee TK, Miyamoto H, Carter HB, Epstein JI. Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails. J Urol 2009;182: 2274–8.
- Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010;28:126–31.
- Thompson IM, Pauler Ankerst D, Chi C, Goodman PJ, Tangen CM, Lippman SM, . Prediction of prostate cancer for patients receiving finasteride: Results from the Prostate Cancer Prevention Trial. J Clin Oncol 2007;25: 3076–81.
- Andriole G, Bostwick D, Brawley O, Gomella L, Marberger M, Montorsi F, . The effect of dutasteride on the utility of PSA for the diagnosis of high-grade and clinically relevant prostate cancer in men with a previous negative biopsy: Results from the REDUCE study. J Urol 2011 (in press).
- Rittmaster RS. Chemoprevention of prostate cancer. Acta Oncol 2010 (this issue).
- Breau RH, Karnes RJ, Jacobson DJ, McGree ME, Jacobsen SJ, Nehra A, . The association between statin use and the diagnosis of prostate cancer in a population based cohort. J Urol 2010;184:494–9.
- Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, . Effect of dutasteride on the risk of prostate cancer. N Engl J Med 2010;362:1192–202.
- Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, . The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349: 215–24.